Company intelligence / Profile preview

Acupath Laboratories

Plainview, New York, United States

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Acupath Laboratories operates as a commercial anatomic and molecular pathology laboratory providing sub-specialized diagnostic services across multiple clinical specialties, including a proprietary urine-based bladder cancer biomarker (Acu-URO17) and COVID-19 PCR testing; it does not develop therapeutic products and has no clinical drug pipeline.

Therapeutic areas: HematologyWomen's HealthOtherDermatologyInfectious DiseasesGastroenterologyOncologyMen's Health
Industry: Molecular Diagnostics

Partnerships

UroGPO (distribution and access partnership for the URO17 bladder cancer biomarker in the United States)CLX Health / TrustAssure network (processing COVID-19 PCR tests through a digital health network)Lumea (digital pathology technology partnership)

Beyond the preview

Go deeper on Acupath Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acupath Laboratories.

Explore the full profile